These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 25047205
1. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Eszlinger M, Hegedüs L, Paschke R. Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205 [Abstract] [Full Text] [Related]
3. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting]. Eszlinger M, Neustadt M, Ruschenburg I, Neumann A, Franzius C, Adam S, Bacher K, Hach A, Hammoser R, Langvogt C, Molwitz T, Paschke R. Dtsch Med Wochenschr; 2014 Mar; 139(10):476-80. PubMed ID: 24570192 [Abstract] [Full Text] [Related]
4. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity. Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M. Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393 [Abstract] [Full Text] [Related]
8. Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology. Le Mercier M, D'Haene N, De Nève N, Blanchard O, Degand C, Rorive S, Salmon I. Histopathology; 2015 Jan; 66(2):215-24. PubMed ID: 24834793 [Abstract] [Full Text] [Related]
9. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice. Witt RL. Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717 [Abstract] [Full Text] [Related]
11. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? Bellevicine C, Sgariglia R, Malapelle U, Vigliar E, Nacchio M, Ciancia G, Eszlinger M, Paschke R, Troncone G. Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198 [Abstract] [Full Text] [Related]
12. The molecular diagnosis and management of thyroid neoplasms. Theoharis C, Roman S, Sosa JA. Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232 [Abstract] [Full Text] [Related]
13. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing. Nikiforova MN, Lepe M, Tolino LA, Miller ME, Ohori NP, Wald AI, Landau MS, Kaya C, Malapelle U, Bellevicine C, Troncone G, Nikiforov YE, Baloch Z. Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051 [Abstract] [Full Text] [Related]
15. Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules. Stence AA, Gailey MP, Robinson RA, Jensen CS, Ma D. Yale J Biol Med; 2015 Dec; 88(4):351-8. PubMed ID: 26604858 [Abstract] [Full Text] [Related]
16. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens. Ko YS, Hwang TS, Kim JY, Choi YL, Lee SE, Han HS, Kim WS, Kim SK, Park KS. Int J Mol Sci; 2017 Apr 12; 18(4):. PubMed ID: 28417935 [Abstract] [Full Text] [Related]
17. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules. Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S. Cancer Cytopathol; 2019 Mar 12; 127(3):146-160. PubMed ID: 30620446 [Abstract] [Full Text] [Related]
18. [Next generation sequencing]. Le Mercier M, D'Haene N, Rorive S, Degand C, De Nève N, Blanchard O, Salmon I. Rev Med Brux; 2016 Mar 12; 37(5):436-438. PubMed ID: 28525213 [Abstract] [Full Text] [Related]
19. Molecular pathology and thyroid FNA. Poller DN, Glaysher S. Cytopathology; 2017 Dec 12; 28(6):475-481. PubMed ID: 29165888 [Abstract] [Full Text] [Related]